
Product Name : Tranexamic Acid Tablets
Trade Name : Clip, Trapic, Cyklokapron
Available Strength : 500mg
Available Combination : Tranexamic Acid + Mefenamic Tablet
Packing : 10X10 Tablets/Box
Pack Insert/Leaflet : Yes
Therapeutic use : Antiplatelets
Production Capacity : 10 million tablet/month
Tranexamic Acid Tablet is a medicine that is used for the treatment of Heavy Menstrual Bleeding, Blood Clotting Problems, Severe Loss Of Blood, Swelling In Various Body Parts and other conditions.
Tranexamic Acid Tablet contains Tranexamic Acid as an active ingredient.
Tranexamic Acid Tablet works by preventing bleeding.
Detailed information related to Tranexamic Acid Tablet’s uses, composition, dosage, side effects and reviews is listed below.
Tranexamic Acid Tablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:
Tranexamic Acid Tablet improves the patient’s condition by performing the following functions:
Tranexamic Acid Tablet is composed of the following active ingredients (salts)
Please note that this medicine may be available in various strengths for each active ingredient listed above.
The following is a list of possible side effects that may occur from all constituting ingredients of Tranexamic Acid Mefenamic Acid Tablet. This is not a comprehensive list. These side effects are possible, but do not always occur. Some of the side effects may be rare but serious. Consult your doctor if you observe any of the following side effects, especially if they do not go away.
Before using this drug, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.). Some health conditions may make you more susceptible to the side effects of the drug. Take as directed by your doctor or follow the direction printed on the product insert. Dosage is based on your condition. Tell your doctor if your condition persists or worsens. Important counseling points are listed below.
Ambroxol salbutamol & Guaiphenesin Syrup improves the patient’s condition by performing the following functions:
The following is a list of possible side-effects that may occur from all constituting ingredients of Ambroxol Salbutamol & Guaiphenesin Syrup. This is not a comprehensive list. These side-effects are possible, but do not always occur. Some of the side-effects may be rare but serious. Consult your doctor if you observe any of the following side-effects, especially if they do not go away.
Before using this drug, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.). Some health conditions may make you more susceptible to the side-effects of the drug. Take as directed by your doctor or follow the direction printed on the product insert. Dosage is based on your condition. Tell your doctor if your condition persists or worsens. Important counseling points are listed below.
The most widely recognized markets for this item incorporate the accompanying nations. If you don’t mind ask with us if your nation or district isn’t recorded:
ASIA: Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Afghanistan, Israel, Jordan, Pakistan, Russia, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, and so forth..
AFRICA: South Africa, Uganda, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, and so forth.
NORTH & SOUTH AMERICA: Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela, USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Brazil, Bahamas, Ecuador, and so forth .
EUROPE: France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Austria, Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, and so forth.
OCEANIA: Fiji, Australia, New Zealand, and so forth.